{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:37:32Z","timestamp":1779928652856,"version":"3.53.1"},"reference-count":100,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2000,6]]},"DOI":"10.1016\/s0952-7915(00)00093-5","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T13:55:25Z","timestamp":1027605325000},"page":"316-322","source":"Crossref","is-referenced-by-count":86,"title":["T cell life and death signalling via TNF-receptor family members"],"prefix":"10.1016","volume":"12","author":[{"given":"Gavin","family":"Screaton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ning","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S0952-7915(00)00093-5_BIB1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev.immunol.17.1.221","article-title":"Mature T lymphocyte apoptosis \u2013 immune regulation in a dynamic and unpredictable antigenic environment","volume":"17","author":"Lenardo","year":"1999","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB2","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1146\/annurev.immunol.17.1.781","article-title":"The central effectors of cell death in the immune system","volume":"17","author":"Rathmell","year":"1999","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1006\/smim.1998.0144","article-title":"Tumor necrosis factor receptor family members in the immune system","volume":"10","author":"Gravestein","year":"1998","journal-title":"Semin Immunol"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0952-7915(99)80054-5","article-title":"Functions of newly identified members of the tumor necrosis factor receptor\/ligand superfamilies in lymphocytes","volume":"11","author":"Kwon","year":"1999","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB5","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0092-8674(00)81874-7","article-title":"Apoptosis by death factor","volume":"88","author":"Nagata","year":"1997","journal-title":"Cell"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB6","doi-asserted-by":"crossref","first-page":"R750","DOI":"10.1016\/S0960-9822(06)90000-1","article-title":"Cell death: TRAIL and its receptors","volume":"7","author":"Golstein","year":"1997","journal-title":"Curr Biol"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0014-5793(98)00791-1","article-title":"Identification and functional characterization of DR6, a novel death domain-containing TNF receptor","volume":"431","author":"Pan","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB8","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1073\/pnas.94.12.5986","article-title":"Fas-ligand: privilege and peril","volume":"94","author":"Green","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB9","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S1074-7613(00)80668-8","article-title":"Inducible nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells","volume":"9","author":"Bonfoco","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB10","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0952-7915(98)80225-2","article-title":"Tumor expression of Fas ligand (CD95L) and the consequences","volume":"10","author":"Walker","year":"1998","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB11","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1182\/blood.V93.3.1000","article-title":"Human immunodeficiency virus type 1 Nef protein sensitizes CD4(+) T lymphoid cells to apoptosis via functional upregulation of the CD95\/CD95 ligand pathway","volume":"93","author":"Zauli","year":"1999","journal-title":"Blood"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB12","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1084\/jem.189.9.1489","article-title":"Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain","volume":"189","author":"Xu","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB13","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1046\/j.1365-2141.1999.01630.x","article-title":"Functional expression of TRAIL by lymphoid and myeloid tumour cells","volume":"106","author":"Zhao","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB14","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.4049\/jimmunol.163.9.4886","article-title":"A \u2018stealth effect\u2019: adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions","volume":"163","author":"Giovarelli","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB15","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/14935","article-title":"Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation","volume":"6","author":"Mongkolsapaya","year":"1999","journal-title":"Nat Struct Biol"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB16","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S1097-2765(00)80207-5","article-title":"Triggering cell death: the crystal structure of Apo2L\/TRAIL in a complex with death receptor 5","volume":"4","author":"Hymowitz","year":"1999","journal-title":"Mol Cell"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB17","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0092-8674(93)90132-A","article-title":"Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation","volume":"73","author":"Banner","year":"1993","journal-title":"Cell"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB18","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0092-8674(00)80294-9","article-title":"Daxx, a novel Fas-binding protein that activates JNK and apoptosis","volume":"89","author":"Yang","year":"1997","journal-title":"Cell"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB19","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1126\/science.281.5384.1860","article-title":"Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx","volume":"281","author":"Chang","year":"1998","journal-title":"Science"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB20","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1073\/pnas.96.4.1252","article-title":"Dissecting Fas signalling with an altered-specificity death-domain mutant: requirement of FADD binding for apoptosis but not Jun N-terminal kinase activation","volume":"96","author":"Chang","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB21","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1101\/gad.13.15.1918","article-title":"Loss of Daxx, a promiscuously interacting protein, results in extensive apoptosis in early mouse development","volume":"13","author":"Michaelson","year":"1999","journal-title":"Genes Dev"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB22","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.1093\/emboj\/18.21.6037","article-title":"Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs)","volume":"18","author":"Torii","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB23","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1093\/emboj\/18.13.3702","article-title":"The Pax3-FKHR oncoprotein is unresponsive to the Pax3-associated repressor hDaxx","volume":"18","author":"Hollenbach","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB24","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/19709","article-title":"The CED-4-homologous protein FLASH is involved in Fas-mediated activation of caspase-8 during apoptosis","volume":"398","author":"Imai","year":"1999","journal-title":"Nature"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB25","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/44317","article-title":"Apoptosis. Searching for FLASH domains","volume":"401","author":"Koonin","year":"1999","journal-title":"Nature"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB26","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1126\/science.281.5381.1305","article-title":"Death receptors: signalling and modulation","volume":"281","author":"Ashkenazi","year":"1998","journal-title":"Science"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB27","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1101\/gad.13.19.2514","article-title":"Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis","volume":"13","author":"Lin","year":"1999","journal-title":"Genes Dev"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB28","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.4049\/jimmunol.162.9.5616","article-title":"Sensitization of AIDS-Kaposi\u2019s sarcoma cells to Apo-2 ligand-induced apoptosis by actinomycin D","volume":"162","author":"Mori","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB29","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1084\/jem.188.8.1391","article-title":"Supraoptimal peptide-major histocompatibility complex causes a decrease in bcl-2 levels and allows tumor necrosis factor alpha receptor II-mediated apoptosis of cytotoxic T lymphocytes","volume":"188","author":"Alexander-Miller","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/26026","article-title":"Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4","volume":"395","author":"Herbein","year":"1998","journal-title":"Nature"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB31","doi-asserted-by":"crossref","first-page":"6346","DOI":"10.1073\/pnas.94.12.6346","article-title":"CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein","volume":"94","author":"Prasad","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB32","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4049\/jimmunol.163.1.194","article-title":"CD30 overexpression enhances negative selection in the thymus and mediates programmed cell death via a Bcl-2-sensitive pathway","volume":"163","author":"Chiarle","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1084\/jem.183.1.159","article-title":"A novel function of CD40: induction of cell death in transformed cells","volume":"183","author":"Hess","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB34","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1084\/jem.183.3.867","article-title":"Signalling through the lymphotoxin beta receptor induces the death of some adenocarcinoma tumor lines","volume":"183","author":"Browning","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB35","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1172\/JCI3492","article-title":"LIGHT, a novel ligand for lymphotoxin beta receptor and TR2\/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer","volume":"102","author":"Zhai","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB36","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1093\/emboj\/18.11.3034","article-title":"Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNFR1 activation by endogenous membrane- anchored TNF","volume":"18","author":"Grell","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB37","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1084\/jem.189.2.441","article-title":"CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell surface fas ligand expression and amplifies fas-mediated hepatocyte death during allograft rejection","volume":"189","author":"Afford","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB38","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/(SICI)1521-4141(199906)29:06<1785::AID-IMMU1785>3.0.CO;2-U","article-title":"TWEAK can induce cell death via endogenous TNF and TNF receptor 1","volume":"29","author":"Schneider","year":"1999","journal-title":"Eur J Immunol"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB39","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S1074-7613(00)80152-1","article-title":"Regulated commitment of TNF receptor signalling: a molecular switch for death or activation","volume":"11","author":"Pimentel-Muinos","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1074-7613(00)80535-X","article-title":"The death domain kinase RIP mediates the TNF-induced NF-kappa B signal","volume":"8","author":"Kelliher","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB41","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/emboj\/17.3.706","article-title":"A dominant interfering mutant of FADD\/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes","volume":"17","author":"Newton","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB42","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0960-9822(98)70182-4","article-title":"p53-dependent impairment of T-cell proliferation in FADD dominant-negative transgenic mice","volume":"8","author":"Zornig","year":"1998","journal-title":"Curr Biol"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB43","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1084\/jem.178.6.2231","article-title":"Fas transduces activation signals in normal human T lymphocytes","volume":"178","author":"Alderson","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB44","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0092-8674(00)81349-5","article-title":"Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor","volume":"87","author":"Rathmell","year":"1996","journal-title":"Cell"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB45","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1073\/pnas.96.14.8104","article-title":"Dichotomy between naive and memory CD4(+) T cell responses to Fas engagement","volume":"96","author":"Desbarats","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB46","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1084\/jem.190.12.1891","article-title":"Caspase activation is required for T cell proliferation","volume":"190","author":"Kennedy","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB47","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1084\/jem.190.12.1879","article-title":"Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells","volume":"190","author":"Alam","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB48","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/385540a0","article-title":"MAP3K-related kinase involved in NF-kappa B induction by TNF, CD95 and IL-1","volume":"385","author":"Malinin","year":"1997","journal-title":"Nature"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB49","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/(SICI)1521-4141(199903)29:03<878::AID-IMMU878>3.0.CO;2-9","article-title":"NF-kappa B regulates Fas\/APO-1\/CD95- and TCR-mediated apoptosis of T lymphocytes","volume":"29","author":"Dudley","year":"1999","journal-title":"Eur J Immunol"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB50","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev.immunol.17.1.331","article-title":"Tumor necrosis factor receptor and Fas signalling mechanisms","volume":"17","author":"Wallach","year":"1999","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB51","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0952-7915(99)80045-4","article-title":"Apoptosis signalling in lymphocytes","volume":"11","author":"Scaffidi","year":"1999","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB52","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB53","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/36593","article-title":"A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function","volume":"390","author":"Anderson","year":"1997","journal-title":"Nature"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB54","doi-asserted-by":"crossref","first-page":"14363","DOI":"10.1074\/jbc.273.23.14363","article-title":"Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL","volume":"273","author":"Emery","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB55","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/25387","article-title":"Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer","volume":"396","author":"Pitti","year":"1998","journal-title":"Nature"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB56","doi-asserted-by":"crossref","first-page":"13733","DOI":"10.1074\/jbc.274.20.13733","article-title":"A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis","volume":"274","author":"Yu","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB57","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.4049\/jimmunol.156.12.4622","article-title":"An N-terminal domain shared by Fas\/Apo-1 (CD95) soluble variants prevents cell death in vitro","volume":"156","author":"Papoff","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB58","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/384372a0","article-title":"A death-domain-containing receptor that mediates apoptosis","volume":"384","author":"Kitson","year":"1996","journal-title":"Nature"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB59","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1073\/pnas.94.9.4615","article-title":"LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing","volume":"94","author":"Screaton","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB60","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/eji.1830200533","article-title":"Tumor necrosis factor inhibitor: purification, NH2-terminal amino acid sequence and evidence for anti-inflammatory and immunomodulatory activities","volume":"20","author":"Seckinger","year":"1990","journal-title":"Eur J Immunol"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB61","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1126\/science.2160731","article-title":"A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins","volume":"248","author":"Smith","year":"1990","journal-title":"Science"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB62","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/0167-5699(95)80030-1","article-title":"Cytokine receptors encoded by poxviruses: a lesson in cytokine biology","volume":"16","author":"Alcami","year":"1995","journal-title":"Immunol Today"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB63","doi-asserted-by":"crossref","first-page":"10040","DOI":"10.1128\/JVI.73.12.10040-10050.1999","article-title":"Human cytomegalovirus UL144 open reading frame: sequence hypervariability in low-passage clinical isolates","volume":"73","author":"Lurain","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB64","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nm0198-031","article-title":"Downregulation of Fas ligand by shedding","volume":"4","author":"Tanaka","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB65","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1084\/jem.186.12.2045","article-title":"Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing","volume":"186","author":"Suda","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB66","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1084\/jem.187.8.1205","article-title":"Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity","volume":"187","author":"Schneider","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB67","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/(SICI)1521-4141(199803)28:03<973::AID-IMMU973>3.0.CO;2-T","article-title":"Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage","volume":"28","author":"Mariani","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB68","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.4049\/jimmunol.163.3.1274","article-title":"Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles","volume":"163","author":"Martinez-Lorenzo","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB69","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.4049\/jimmunol.161.5.2195","article-title":"TNF related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells","volume":"161","author":"Thomas","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB70","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1084\/jem.188.12.2375","article-title":"Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells","volume":"188","author":"Zamai","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB71","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1084\/jem.190.8.1155","article-title":"Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)","volume":"190","author":"Fanger","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB72","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.4049\/jimmunol.163.4.1906","article-title":"Expression and function of TNF related apoptosis-inducing ligand on murine activated NK cells","volume":"163","author":"Kayagaki","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB73","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1084\/jem.189.9.1451","article-title":"Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: a novel mechanism for the antitumor effects of type I IFNs","volume":"189","author":"Kayagaki","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB74","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.4049\/jimmunol.162.5.2639","article-title":"Involvement of TNF related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity","volume":"162","author":"Kayagaki","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB75","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1126\/science.277.5327.815","article-title":"An antagonist decoy receptor and a death domain-containing receptor for TRAIL","volume":"277","author":"Pan","year":"1997","journal-title":"Science"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB76","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.277.5327.818","article-title":"Control of TRAIL-induced apoptosis by a family of signalling and decoy receptors","volume":"277","author":"Sheridan","year":"1997","journal-title":"Science"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB77","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1084\/jem.186.7.1165","article-title":"Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family","volume":"186","author":"Degli Esposti","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB78","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4049\/jimmunol.160.1.3","article-title":"Lymphocyte inhibitor of TRAIL (TNF related apoptosis-inducing ligand): a new receptor protecting lymphocytes from the death ligand TRAIL","volume":"160","author":"Mongkolsapaya","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB79","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0960-9822(06)00422-2","article-title":"A novel receptor for Apo2L\/TRAIL contains a truncated death domain","volume":"7","author":"Marsters","year":"1997","journal-title":"Curr Biol"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB80","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1074-7613(00)80399-4","article-title":"The novel receptor TRAIL-R4 induces NF-kappa B and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain","volume":"7","author":"Degli Esposti","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB81","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0014-5793(98)00135-5","article-title":"TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling","volume":"424","author":"Pan","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB82","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/5517","article-title":"Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo","volume":"5","author":"Walczak","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB83","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1172\/JCI6926","article-title":"Safety and antitumor activity of recombinant soluble Apo2 ligand","volume":"104","author":"Ashkenazi","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB84","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0952-7915(98)80224-0","article-title":"TRAIL: a molecule with multiple receptors and control mechanisms","volume":"10","author":"Griffith","year":"1998","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB85","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.4049\/jimmunol.161.6.2833","article-title":"Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells","volume":"161","author":"Griffith","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB86","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.4049\/jimmunol.162.5.2597","article-title":"Functional analysis of TRAIL receptors using monoclonal antibodies","volume":"162","author":"Griffith","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB87","first-page":"2747","article-title":"Relation of TNF related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma","volume":"59","author":"Zhang","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB88","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0952-7915(98)80223-9","article-title":"Inhibition of fas death signals by FLIPs","volume":"10","author":"Tschopp","year":"1998","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB89","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/40657","article-title":"Inhibition of death receptor signals by cellular FLIP","volume":"388","author":"Irmler","year":"1997","journal-title":"Nature"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB90","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.4049\/jimmunol.162.9.5205","article-title":"Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis","volume":"162","author":"Algeciras-Schimnich","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB91","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.4049\/jimmunol.163.3.1315","article-title":"Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cells","volume":"163","author":"Inaba","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB92","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1084\/jem.190.11.1679","article-title":"FLICE-inhibitory protein expression during macrophage differentiation confers resistance to fas-mediated apoptosis","volume":"190","author":"Perlman","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB93","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1521-4141(200001)30:1<155::AID-IMMU155>3.0.CO;2-X","article-title":"Inhibition of Fas-mediated apoptosis by the B cell antigen receptor through c-FLIP","volume":"30","author":"Wang","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB94","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1074\/jbc.274.3.1541","article-title":"The role of c-FLIP in modulation of CD95-induced apoptosis","volume":"274","author":"Scaffidi","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB95","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1074-7613(00)80150-8","article-title":"Autoimmunity as a consequence of retrovirus-mediated expression of c-FLIP in lymphocytes","volume":"11","author":"Van Parijs","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB96","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1074-7613(00)80566-X","article-title":"Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis","volume":"8","author":"Refaeli","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB97","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/40657","article-title":"Inhibition of death receptor signals by cellular FLIP","volume":"388","author":"Irmler","year":"1997","journal-title":"Nature"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB98","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.4049\/jimmunol.161.8.3936","article-title":"FLIP prevents apoptosis induced by death receptors but not by perforin\/granzyme B, chemotherapeutic drugs, and gamma irradiation","volume":"161","author":"Kataoka","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB99","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.190.7.1025","article-title":"The inhibitor of death receptor signalling, FLICE-inhibitory protein defines a new class of tumor progression factors","volume":"190","author":"Djerbi","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/S0952-7915(00)00093-5_BIB100","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1084\/jem.190.7.1033","article-title":"Immune escape of tumors in vivo by expression of cellular FLICE- inhibitory protein","volume":"190","author":"Medema","year":"1999","journal-title":"J Exp Med"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791500000935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791500000935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T22:53:36Z","timestamp":1680994416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791500000935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":100,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["S0952791500000935"],"URL":"https:\/\/doi.org\/10.1016\/s0952-7915(00)00093-5","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2000,6]]}}}